Table 1.
Vaccine | Effectiveness (%) in Preventing | |||||
---|---|---|---|---|---|---|
Ancetral Variant | Delta Variant | Omicron Variant | ||||
Severe Disease | Infection | Severe Disease | Infection | Severe Disease | Infection | |
Moderna | 97 | 92 | 97 | 91 | 73 | 48 |
Pfizer/BioNTech | 95 | 86 | 95 | 84 | 72 | 44 |
Sputnik | 92 | 86 | 89 | 85 | 67 | 44 |
Novavax | 89 | 83 | 86 | 82 | 65 | 43 |
Covaxin | 78 | 73 | 76 | 72 | 57 | 38 |
Oxford/Astra-Zeneca | 94 | 63 | 94 | 69 | 71 | 36 |
Sinopharm | 73 | 68 | 71 | 67 | 53 | 35 |
Janssen | 86 | 72 | 76 | 64 | 57 | 33 |
CoronaVac | 50 | 47 | 49 | 46 | 37 | 24 |
Convidecia | 66 | 62 | 64 | 61 | 48 | 22 |